Success Metrics

Clinical Success Rate
90.0%

Based on 27 completed trials

Completion Rate
90%(27/30)
Active Trials
0(0%)
Results Posted
33%(9 trials)
Terminated
3(8%)

Phase Distribution

Ph phase_3
8
22%
Ph phase_4
8
22%
Ph phase_2
6
17%
Ph not_applicable
4
11%
Ph phase_1
5
14%

Phase Distribution

5

Early Stage

6

Mid Stage

16

Late Stage

Phase Distribution31 total trials
Phase 1Safety & dosage
5(16.1%)
Phase 2Efficacy & side effects
6(19.4%)
Phase 3Large-scale testing
8(25.8%)
Phase 4Post-market surveillance
8(25.8%)
N/ANon-phased studies
4(12.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.1%

27 of 31 finished

Non-Completion Rate

12.9%

4 ended early

Currently Active

0

trials recruiting

Total Trials

36

all time

Status Distribution
Completed(27)
Terminated(4)
Other(5)

Detailed Status

Completed27
unknown5
Terminated3
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
36
Active
0
Success Rate
90.0%
Most Advanced
Phase 4

Trials by Phase

Phase 15 (16.1%)
Phase 26 (19.4%)
Phase 38 (25.8%)
Phase 48 (25.8%)
N/A4 (12.9%)

Trials by Status

unknown514%
terminated38%
withdrawn13%
completed2775%

Recent Activity

Clinical Trials (36)

Showing 20 of 36 trialsScroll for more
NCT04115098Phase 2

Individualizing Anti-Inflammatory Medications for Adults With Axial Spondyloarthritis: A Series of N-of 1 Trials

Terminated
NCT01147289Phase 3

Efficacy and Safety of Injectable Association of Dexamethasone, Dipyrone and Hydrocobalamin in Lumbar Sciatic Pain

Completed
NCT05974501Phase 4

Pre vs Post Block in Total Knee Arthroplasty (TKA)

Completed
NCT02183129Phase 4

Study to Assess the Efficacy and Safety of Meloxicam vs. Diclofenac SR in Patients With Osteoarthritis of the Knee

Completed
NCT03896009Phase 3

Maximizing Outcomes in Treating Acute Migraine

Completed
NCT04766996Phase 4

PROUD Study - Preventing Opioid Use Disorders

Terminated
NCT02706054Phase 3

Treatment of Recent Onset Low Back Pain With Periradicular Injections of Meloxicam

Completed
NCT04771741

Opiate Free Multimodal Pain Pathway in Elective Foot and Ankle Surgery: A Prospective Study

Completed
NCT03586934Phase 3

Multimodal Analgesia in Shoulder Arthroplasty

Withdrawn
NCT02078102Phase 2

A Phase II Trial Using Meloxicam Plus Filgrastim in Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma

Completed
NCT01430559Not Applicable

Effect Of Meloxicam Versus Placebo In Mainland Chinese Patients With Osteoarthritis Of The Knee

Completed
NCT03473665Phase 4

Non-Steroidal Anti-inflammatory Drugs in Axial Spondyloarthritis

Terminated
NCT04480359Phase 2

Bawei Shenqi Pill in the Treatment of Ankylosing Spondylitis

Unknown
NCT04490434Phase 1

Drug-drug Interaction Between DWP14012 and Three Different Kinds of NSAIDs

Unknown
NCT02003625Phase 2

Meloxicam vs Placebo for Mobilization

Completed
NCT04322175Phase 1

Pharmacokinetic and Tolerance Study of Meloxicam Eye Drops in Healthy Volunteers

Unknown
NCT04003350Not Applicable

The Effect of Prolonged Multimodal Analgesic Regimen on Post Hospital Discharge Opioid Use and Pain Control After Primary Total Knee Arthroplasty

Completed
NCT02255045Phase 2

Assessment of a Vaginal Ring With Meloxicam in the Treatment of Dysmenorrhea

Completed
NCT00618163Not Applicable

Bioequivalency Study of Meloxicam Tablets Under Fasting Conditions

Completed
NCT00601887Not Applicable

Bioequivalency Study of Meloxicam Tablets Under Fed Conditions

Completed

Drug Details

Intervention Type
DRUG
Total Trials
36